Japan Central Social Insurance Medical Council To Entrust External Institutions For Advanced Evaluation Of Cancer Therapies
This article was originally published in PharmAsia News
Executive Summary
Japan’s Central Social Insurance Medical Council approved on Sept. 4 a new operational plan to ensure that unapproved off-label cancer drugs can come into use more quickly.